Representing PSC Patients at the ERN RARE-LIVER Annual Meeting
Martine Walmsley, PSC Support Head of Research Strategy, represented patients with rare liver diseases at the ERN RARE-LIVER annual meeting.
Register for our 20K Your Way Challenge 2025
Join #TeamPSCSupport for our 20K Your Way Challenge. Choose your own 20K challenge to take on between 1st – 30th April 2025. Register now.
Breaking News from ICR
Researchers at the Institute of Cancer Research (ICR) and St Mark’s Hospital in London have shared news today that they have developed a test to predict bowel cancer risk in people with inflammatory bowel disease.
Great North Run 2025 Places
We’ve got places available for this iconic half marathon. Register to run for #TeamPSCSupport!
PSC Support’s 20K Your Way Challenge 2025
Register your interest to find out more about our new community fundraising challenge.
SPRING Clinical Trial Update
Clinical Data from Phase 2 SPRING Trial Shows CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of PSC.
Promising Preclinical Data from Rectify Pharma
Rectify Pharma presented promising preclinical data for RTY-694, their lead candidate for treating primary sclerosing cholangitis and other hepatobiliary diseases, at the 75th Annual Liver Meeting® 2024.